Twitter universal website tag code Twitter website tag code

[Skip to content]

Private hospital continually investing in advanced diagnostic and treatment technologies
Search our Site

Clinical Oncologist Stephen Mangar, Private Clinic Treatment, Self Pay Patients

Dedicated GP referral service

Call Cromwell Direct to make a referral on

+44 (0)800 783 9229

More about Cromwell Direct

Make a referral

Refer a patient to us by telephone, fax or email

How to refer

Make an appointment

8am-8pm Monday to Friday
8am-2pm Saturday
Call our Contact Centre on

+44 (0)20 7460 5700

Contact Us

Dr Stephen Mangar, Consultant Clinical Oncologist

Specialising in:

Urological cancer, chemoradiotherapy for lung cancer

(Unnamed Fieldset)
Specialist Details
Full name

Dr Stephen Mangar

Qualifications

MB ChB MRCP MSc FRCR

Title

Consultant Clinical Oncologist

Specialties

Oncology - clinical (radiation), Oncology - medical

Site specialisation

Genito-urinary, GI

Site specialisation 2

Genito-urinary, GI

Clinical interests

Urological cancer, chemoradiotherapy for lung cancer

Background Information
Biography

Dr Mangar has trained  in all aspects of oncology including radiotherapy and chemotherapy.  For radiotherapy particular interest in image guided conformal radiotherapy, and high dose rate brachytherapy for prostate cancer. He is available for daily consultation. For chemotherapy, his interest lies in chemotherapy for metastatic prostate cancer and exploring new chemoradiotherapy regimes for lung cancer.

Languages spoken

English

Availability
Regular Cromwell clinics

Yes

Clinic days

Mon: ad hocTue: Wed: ad hocThurs: amFri: ad hocSat:

Appointments telephone number

020 8383 3170

Additional Career Information
Year qualified

1994

Memberships

MRCP, FRCR, ESTRO,  AACR, British Uro-Oncology Group

NHS hospitals

Hammersmith Hospital

Posts

Central Middlesex Hospital

Research interests

Image guided radiotherapy

Key published papers

Mangar SA, MR Sydes, Tucker HL, Coffey J. et al.Evaluating the relationship between erectile dysfunction and dose received by the penile bulb in patients undergoing conformal radiotherapy for prostate cancer: Analysis of data from the MRC RT01 dose escalation trial.  Radiother Oncol 2006, 80:355-362. 
Mangar SA, Foo K, Norman A, Shaidi M et al.Evaluating the effect of reducing the high dose volume on toxicity of radiotherapy in the treatment of bladder cancer. Clinical Oncology 2006, 18(6):466-473. 
Mangar SA, Slevin NJ, Mais KL, and Sykes AJ.Evaluating predictive factors for determining enteral nutrition in patients receiving radical radiotherapy for head and neck cancer. Radiother Oncol 2006, 78(2):152-8. 
McNair H, Coffey J, Mangar SA, et al.A comparison of CT and ultrasound based images to localize the prostate  for external beam radiotherapy. Int J Radiat Oncol Biol Phys 2006, 63(3):678-87. 
Mangar SA, Thompson A, Miles E, Huddart R, et alThe feasibility of using gold seeds to act as fiducial markers for bladder localisation during radiotherapy. British Journal of Radiology Published online before print November 22, 2006  

Website

Media coverage

Our consultants regularly contribute to hospital publications, as well as national newspaper articles and television coverage.